Finance

Lists
DPHARMA:KLSE
Duopharma Biotech Bhd
1,13 MYR
+0,89%
(+0,0100) 1D
9 հոկ, 17:00:00 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for DPHARMA...
Open
1,13 MYR
High
1,14 MYR
Low
1,13 MYR
Mkt. cap
1,09 մլրդ
Avg. vol.
394,22 հզր
Volume
0,00
Dividend
4,03%
Quarterly dividend
0,01 MYR
Ex-dividend date
03 սեպ, 2026 թ.
P/E ratio
10,64
52-wk high
1,57 MYR
52-wk low
1,12 MYR
EPS
0,11 MYR
Shares outstanding
961,94 մլն
No. of employees
2 հզր
Open
1,13 MYR
High
1,14 MYR
Low
1,13 MYR
Mkt. cap
1,09 մլրդ
Avg. vol.
394,22 հզր
Volume
0,00
Dividend
4,03%
Quarterly dividend
0,01 MYR
Ex-dividend date
03 սեպ, 2026 թ.
P/E ratio
10,64
52-wk high
1,57 MYR
52-wk low
1,12 MYR
EPS
0,11 MYR
Shares outstanding
961,94 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
About Duopharma Biotech Bhd
CEO-
Employees2 հզր
Founded1978
Headquarters-
Sector-
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
222,49 մլն
224,69 մլն
247,88 մլն
234,36 մլն
Cost of goods sold
131,74 մլն
128,63 մլն
150,58 մլն
134,89 մլն
Cost of revenue
131,74 մլն
128,63 մլն
150,58 մլն
134,89 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,11 մլն
64,37 մլն
52,42 մլն
55,74 մլն
Operating expense
56,18 մլն
66,90 մլն
52,88 մլն
55,60 մլն
Total operating expenses
187,93 մլն
195,53 մլն
203,46 մլն
190,50 մլն
Operating income
34,56 մլն
29,15 մլն
44,42 մլն
43,86 մլն
Other non operating income
-
-590,00 հզր
-
-
EBT including unusual items
29,68 մլն
24,91 մլն
40,41 մլն
39,30 մլն
EBT excluding unusual items
29,68 մլն
24,90 մլն
40,41 մլն
39,30 մլն
Income tax expense
7,11 մլն
5,86 մլն
9,69 մլն
9,43 մլն
Effective tax rate
23,96%
23,52%
23,99%
24,00%
Other operating expenses
76,00 հզր
2,00 մլն
468,00 հզր
-130,00 հզր
Net income
22,57 մլն
19,05 մլն
30,71 մլն
29,87 մլն
Net profit margin
10,14%
8,48%
12,39%
12,75%
Earnings per share
-
-
-
-
Interest and investment income
1,53 մլն
1,52 մլն
1,58 մլն
1,34 մլն
Interest expense
-6,40 մլն
-5,19 մլն
-5,60 մլն
-5,89 մլն
Net interest expenses
-4,88 մլն
-3,67 մլն
-4,02 մլն
-4,56 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
45,74 մլն
32,61 մլն
55,43 մլն
54,75 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps